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Overexpression, purification and biochemical characterization of a class A
high-molecular-mass penicillin-binding protein (PBP), PBP1* and its soluble
derivative from Mycobacterium tuberculosis
Sanjib BHAKTA and Joyoti BASU1
Department of Chemistry, Bose Institute, 93/1 Acharya Prafulla Chandra Road, Calcutta 700009, India
The product of the gene ponA present in cosmid MTCY21D4,
one of the collection of clones representing the genome of
Mycobacterium tuberculosis, has been named penicillin-binding
protein 1* (PBP1*), by analogy to the previously characterized
PBP1* of M. leprae. This gene has been overexpressed in
Escherichia coli. His
’
-tagged PBP1* localizes to the membranes
of induced E. coli cells. Its susceptibility to degradation upon
proteinase K digestion of spheroplasts from E. coli expressing
the protein supports the view that the majority of the protein
translocates to the periplasmic side of the membrane. Recom-
binant PBP1* binds benzylpenicillin and several other b-lactams,
notably cefotaxime, with high affinity. Truncation of the N-
terminal 64 amino acid residues results in an expressed protein
INTRODUCTION
The advent of multidrug-resistant Mycobacterium tuberculosis
strains has necessitated a search for new antimycobacterial
agents as well as a re-evaluation of the potential of existing
antimicrobials. In spite of reports that some b-lactam antibiotics
appear to be active in itro [1–3] and in io [4], M. tuberculosis
historically has been regarded as intrinsically resistant, due to the
presence of one or more b-lactamases [5,6] and its lipid-rich outer
cell wall [7]. However, the targets of the b-lactams, the penicillin-
binding (PB) proteins (PBPs), remain to be characterized. In
order for a b-lactam to be effective, it is a prerequisite that its
targets should bind with high affinities to the b-lactams. Previously,
it has been reported [8] that the PBPs of M. tuberculosis bind b-
lactams at clinically relevant antibiotic concentrations, making it
important to undertake a serious evaluation of the potential of b-
lactam antibiotics through the characterization of these targets.
PBPs are a set of membrane-bound proteins that catalyse the
final steps of bacterial cell wall peptidoglycan synthesis. The low-
molecular-mass PBPs are single catalytic entities possessing dd-
peptidase, esterase and thiol esterase activities [9]. The high-
molecular-mass PBPs of classes A and B are involved in cell wall
peptidoglycan assembly and cell morphogenesis. These are
multidomain proteins consisting of an N-terminal module fused
to a C-terminal module harbouring the transpeptidase activity
and capable of binding penicillin [10]. Transglycosylase
activity has been attributed to the N-terminal non-PB (n-PB)
module of class A high-molecular-mass PBPs, although this has
Abbreviations used: CTAB, cetyltrimethylammonium bromide ; IPTG, isopropyl b-D-thiogalactoside ; NTA, nitrilotriacetate ; ORF, open reading frame;
PB, penicillin-binding; PBP, PB protein ; n-PB module, non-PB module ; PB-PBP1*, truncated PBP1* lacking residues Val2–Gln271 ; s-PBP1*, soluble
PBP1* (truncated PBP1* lacking residues Gly95–Gln143) ; Zwittergent 3–12, N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulphonate.
1 To whom correspondence should be addressed (e-mail joyoti!bosemain.boseinst.ac.in).
present exclusively in inclusion bodies and unable to associate
with the membrane. The C-terminal module encompassing amino
acids 272–663 can be extracted from inclusion bodies under
denaturing conditions using guanidine}HCl and refolded to give
a protein fully competent in penicillin-binding. Deletion of
Gly*&–Gln"%$ results in the expression of a protein, which is
localized in the cytosol. The soluble derivative of PBP1* binds
benzylpenicillin with the same efficiency as the full-length protein.
This is the first report of a soluble derivative of a class A high-
molecular-mass PBP.
Key words: cell wall biosynthesis, b-lactam, transpeptidase.
been clearly identified only in Escherichia coli PBPs 1a and 1b
[11]. The completion of the genome sequence of M. tuberculosis
[12] has revealed the presence of two open reading frames
(ORFs), Rv3682 and Rv0050, encoding two putative class A
high-molecular-mass PBPs. Since the high-molecular-mass PBPs
are essential enzymes in the bacterial cell wall peptidoglycan
synthesizing machinery, it was reasoned that, as a step towards
evaluating potential drugs directed against these targets, the first
phase would be to characterize the proteins encoded by these
genes, and attempt to generate soluble forms of these enzymes to
facilitate structural studies. In the present study, we report the
overexpression and characterization of the M. tuberculosis high-
molecular-mass PBP1* encoded by the ORF Rv0050 [12] and its
soluble derivative, soluble PBP-1* (s-PBP1*).
MATERIALS AND METHODS
Materials
["%C]Benzylpenicillin was purchased from Amersham Biosciences
(Little Chalfont, Bucks., U.K.). The vector pET-28a(›) was
from Novagen (Madison, WI, U.S.A.) and oligonucleotides were
purchased from Life Technologies (Rockville, MD, U.S.A.).
Transformations were routinely carried out in E. coli DH5a. The
expression of recombinant PBP1* and its derivatives was carried
out in E. coli BL21(DE3) or E. coli Top10. N-dodecyl-N,N-
dimethyl-3-ammonio-1-propanesulphonate (Zwittergent 3–12),
Nonidet P40, cetyltrimethylammonium bromide (CTAB),
CHAPS, Triton X-100, arabinose, benzylpenicillin, cefuroxime,
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cefotaxime, cefoxitin, ceftriaxone, ampicillin and amoxycillin
were purchased from Sigma Chemical Co. (St. Louis, MO,
U.S.A.) ; isopropyl b-d-thiogalactoside (IPTG) and kanamycin
were from Amersham Biosciences.
Construction of the expression systems
The cosmid MTCY21D4 (a gift from Dr Stewart Cole, Institut
Pasteur, Paris, France) was amplified in E. coli DH5a and
digested with BamHI. A 6.6-kb fragment containing the gene pon
A was cloned in the vector pK19 [13] to give the plasmid pJS251.
The gene pon A was amplified from pJS251 using the primers
5«-TTTAAGCTTCATATGGTCACCTTCACG-3« (sense) and 5«-
ATGAATTCGTGGGAGTCTCACCG-3« (antisense ; primer a).
The bold letters in these primer sequences and those below
represent the restriction enzyme sites indicated. The ponA gene
was ligated into the vector pET28a between the NdeI and EcoRI
sites to give pJS253 (encoding [His]tag-PBP1*). All recombinant
proteins described below carried the His
’
-tag at the N-terminus.
The product obtained by PCR using the primer pair 5«-CGGA-
TCCATATGGAAGACCGCAATTTCTATTCG-3« (sense) and
primer a (antisense), and pJS253 as template, was cloned between
the BglII and EcoRI sites of the pBAD-HisA vector (Invitrogen,
Carlsbad, CA, U.S.A.) to give pJS255 [encoding (DV2-A64)-
PBP1*; PBP1* lacking Val#–Ala’%]. The product obtained using
the primer pair 5«-TTTAAGCTTCATATGGGCGGATCGA-
CGATTACCC-3« (sense) and primer a (antisense) was cloned
between the NdeI and EcoRI sites (indicated in bold) in pET28a
to give pJS257 [encoding (DV2-Q94)PBP1*; PBP1* lacking
Val#–Gln*%]. pJS259 [encoding (DV2-S137)PBP1*; PBP1*
lacking Val#–Ser"$(] was obtained by PCR using the primer
pair 5«-ATGGATCCATATGAAAGACGATGTGCTGCAG-3«
(sense) and primer a (antisense), followed by cloning between the
NdeI and EcoRI sites of pET28a. pJS255 was digested with XhoI
to remove the portion of the gene encoding the first 258 amino
acid residues of PBP1*. The overhangs were religated to yield
pJS261 encoding (DV2-S258)PBP1*. pJS262 [encoding (DV2-
Q271)PBP1*; PBP1* lacking Val#–Gln#("] was generated by
PCR using the primer pair 5«-TTGGATCCATATGGGGCTG-
GTGGTCACCAC-3« (sense) and primer a (antisense), followed
by cloning between the NdeI and EcoRI sites of pET28a. pJS253
was digested to completion with PstI to remove a 144-bp
fragment, followed by religation to give pJS263 [encoding (DG95-
Q143)PBP1*; PBP1* lacking Gly*&–Gln"%$]. All constructs were
checked by DNA sequencing.
Expression and protein purification
Genes cloned in the vector pET28a were expressed in E. coli
BL21(DE3). Cells harbouring the various plasmids were grown
overnight with shaking at 37 °C in Luria–Bertani broth supple-
mented with 50 lg}ml kanamycin. E. coli transformants, grown
to a D
’!!
of 0.6, were induced with 100 lM IPTG for 3 h at
30 °C. Genes cloned in the pBAD-HisA vector were expressed in
E. coli Top10 by induction with 0.0002% arabinose for 4 h at
37 °C. pBAD was chosen as the araBAD promoter of E. coli
allows regulated expression, thus facilitating optimum expression
of soluble protein. Cells were harvested, resuspended in a solution
containing 10 mM Tris}HCl (pH 7.4), 1 mM MgCl
#
and 1 lg}ml
DNAse and sonicated at 200 W for 2 min. Unbroken cells and
debris were removed by centrifugation at 600 g for 10 min.
Inclusion bodies were obtained by centrifugation at 5000 g for
10 min, and plasma membranes by centrifugation at 100000 g
for 30 min. Both inclusion bodies and plasma membranes were
washed twice and stored at fi20 °C until further use.
In order to purify the full-length recombinant PBP1*, mem-
branes (10 mg of protein) were suspended in 5 ml of 10 mM
Tris}HCl (pH 8) containing 1% (w}v) Zwittergent 3–12 and
maintained at 4 °C for 40 min. After centrifugation at 100000 g
for 30 min, the supernatant was removed and NaCl was added to
give a final concentration of 0.5 M. The supernatant was loaded
on to a 1 ml Ni#+-nitrilotriacetate (NTA)–agarose column
(Qiagen GmbH, Hilden, Germany) equilibrated with buffer A
[50 mM sodium phosphate buffer (pH 7.4) and 0.5 M NaCl] and
the column was washed with buffer A containing 100 mM
imidazole. PBP1* was eluted with a gradient of 100–
200 mM imidazole}1% (w}v) Zwittergent 3–12 in buffer A. All
steps were carried out at 4 °C.
Interaction of PBP1* with b-lactam antibiotics
This was interpreted on the basis of the following three-step
scheme [14,15] :
E›I%
K
EI!
k
#
EI*!
k
$
E›P
where E is the active enzyme, I is the b-lactam compound, EI
is the Henri–Michaelis complex, EI* is the acyl-enzyme, P is
the biologically inactive product, K is the dissociation con-
stant of the Henri–Michaelis complex, k
#
is the first-order rate
constant for acyl-enzyme formation and k
$
is the first-order
rate constant for the deacylation step.
The kinetic parameters k
#
}K (the second-order rate constant
for the acylation step) and k
$
of interaction with ["%C]-
benzylpenicillin were determined as described previously [15,16].
Knowing these values, the k
#
}K value for non-radioactive b-
lactams was determined in a one-step competition with ["%C]-
benzylpenicillin, as described by Frere et al. [17,18] from the
equation
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The amount of radioactive acyl-enzyme formed with b-lactam 2
(["%C]benzylpenicillin) in the absence ([EfiD*
#
]
!
; where D*
#
is the
concentration of ["%C]benzylpenicillin) or presence ([EfiD*
#
]) of
b-lactam 1 (non-radioactive b-lactam), was measured by densito-
metric scanning of the fluorograms and using the equation
[EfiD*
"
]fl [EfiD*
#
]
!
fi[EfiD*
#
] (where D*
"
is the concentration
of non-radioactive b-lactam); [D*
"
] and [D*
#
]& [E
!
]. Incubation of
the enzyme with antibiotics was performed for three different
periods, with the time of contact between the enzyme and the
antibiotic being short in each case compared with the lifetime
of the EfiD* adducts. Under these conditions the ratio of
[EfiD*
"
]}[EfiD*
#
] was independent of the time of contact.
["%C]Benzylpenicillin (0.1 mM) binding assays were carried out
at 25 °C for 2 min.
The values of k
#
}K given in theResults section aremeans‡S.D.
of three independent determinations.
Preparation and protease treatment of spheroplasts from E. coli
transformants
E. coli cells were pelleted and resuspended at 2‹10"! cells}ml in
15 mM Tris}HCl (pH 8) containing 12.5% (w}v) sucrose. The
cell suspensions were then treated with the same buffer containing
2 mg}ml lysozyme and 5 mM EDTA for 25 min at 30 °C. Under
these conditions all the cells were converted into spheroplasts.
Where necessary, spheroplasts were pelleted and the supernatant
was used to detect periplasmic proteins. Spheroplasts were lysed
by osmotic shock and the membranes were pelleted by centri-
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fugation (600 g for 10 min at 25 °C). The supernatant contained
the cytosolic proteins.
Western blotting
Western blotting was performed on periplasmic and cytosolic
proteins using either an anti-His antibody (1:2500 dilution) or an
antibody against M. leprae PBP1* (1:1000 dilution; the antibody
is also able to detect full-length M. tuberculosis PBP1*). A
horseradish peroxidase-conjugated anti-(rabbit IgG) antibody
was used as the secondary antibody, and colour development was
performed using 4-chloro-1-naphthol.
RESULTS
M. tuberculosis PBP1* sequence analysis
From sequence alignments, the ORF Rv0050 (ponA) was pre-
dicted to encode a class A high-molecular-mass PBP from M.
tuberculosis, which we have named M. tuberculosis PBP1* by
analogy with the previously reported PBP1* from M. leprae [19].
A genome-based search also identified Rv3682 as the ORF
encoding the putative PBP1 from M. tuberculosis, which appears
to be the counterpart of PBP1 from M. leprae [20]. A similarity
search of the amino acid sequence using the BLAST algorithm
[21] showed that M. tuberculosis PBP1* shared 83% identity
Figure 1 Modular design of the class A PBP1* from M. tuberculosis (Mtu1*) and M. leprae (Mel1*)
The conserved motifs along the amino acid sequence have been designated as described by Goffin and Ghuysen [10]. The numbers between the amino acid residues indicate the number of amino
acids between each sequence. X represents any amino acid, and ' depicts the intermodule junction. The EMBL DNA databank accession numbers for Mtu1* and Mle1* are Z80775 and L39923
respectively.
Figure 2 Overexpression, purification and binding of recombinant PBP1* to [14C]benzylpenicillin
(A) Coomassie-Blue-stained gels of membranes fractions of induced E. coli cells expressing PBP1* (lane a), Zwittergent 3–12-solubilized membrane proteins (lane b), purified PBP1* (lane c) and
purified PBP1* labelled with [14C]benzylpenicillin (lane d). (B) Coomassie-Blue-stained gels of uninduced cells (lane a), induced cells (lane b), inclusion bodies from cells expressing PB-PBP1*
(lane c), purified PB-PBP1* (lane d) and purified PB-PBP1* labelled with [14C]benzylpenicillin (lane e). (C) Coomassie-Blue-stained gels of induced cells expressing s-PBP1* (lane a), cell-free
supernatant of the same cells (lane b), purified s-PBP1* (lane c) and purified s-PBP1* labelled with [14C]benzylpenicillin (lane d). Western blotting of the periplasmic (lane e) and cytosolic (lane
f ) extracts from cells over expressing s-PBP-1* and crude extract from induced cells expressing s-PBP1* (lane g) probed with the anti-His antibody. The amount of protein loaded in each
lane was derived from an equal number of cells. Molecular-mass markers are indicated (in kDa) on the right.
with M. leprae PBP1*. M. tuberculosis PBP1* was characterized
by the presence of the conserved modules of the class A high-
molecular-mass PBPs, as shown in Figure 1. The n-PB module,
containing the characteristic conserved motifs 1–6, is fused to a
C-terminal PB module, containing motifs 7–9, which is connected
to a C-terminal extension of 127 amino acid residues. From the
hydropathy plot, Met"–Asn## was identified as the pseudo-signal
peptide. Ser$$* of the PB module was assumed to be the active-
site serine.
Expression of pon A in E. coli and properties of recombinant
PBP1*
Expression of recombinant PBP1* in E. coli BL21(DE3)}pJS253
was inducible by IPTG and under the control of the T7 promoter
and lac operator. The overexpressed PBP1* localized to the
membrane (Figure 2A, lane a).
Experiments were performed to confirm that the majority of
the polypeptide chain of the membrane-bound His-tagged PBP1*
that had translocated to the periplasmic side of the membrane
adopted the predicted membrane topology. E. coli transformants
were grown, induced with IPTG and converted into spheroplasts.
Spheroplasts were treated with varying concentrations of pro-
teinase K for 25 min at 30 °C. The amount of PBP1* left intact
in the protease-treated spheroplasts was evaluated by SDS}
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Figure 3 Protease digestion of PBP1* in spheroplasts
Spheroplasts of cells expressing full-length PBP1* were incubated with proteinase K at 0 (lane
a), 40 (lane b), 80 (lane c), 200 (lane d) and 1000 (lane e) lg/ml, as described in the Materials
and methods section. Samples were fractionated by SDS/PAGE, transferred on to nitrocellulose
membranes and probed with antibodies against M. leprae PBP1*.
PAGE and Western blotting using an antibody against M. leprae
PBP1*. PBP1* was totally degraded in spheroplasts at
1000 lg}ml proteinase K (Figure 3), supporting the view that
PBP1* adopts the expected membrane topology.
Purification of PBP1*
Extraction of PBP1* from the membranes was attempted using
various detergents [1% (v}v) Triton X-100, 1% (w}v) CTAB,
1% (w}v) Zwittergent 3–12, 1% (v}v) Nonidet P40 and 1%
(w}v) CHAPS], incubation temperatures of 25 and 4 °C and
different incubation times. PBP1* was not solubilized with
Nonidet P40, and was poorly extracted with Triton X-100
and CHAPS. Extraction was most efficient with CTAB and
Zwittergent 3–12 at 4 °C. The Zwittergent 3–12-solubilized
PBP1* was adsorbed on to a Ni#+-NTA–agarose column and
subsequently eluted with a gradient of 100–200 mM imidazole}
Zwittergent 3–12 in buffer A. The purified PBP1* (Figure 2A,
lane c) was " 95% homogeneous, as determined by SDS}PAGE,
and was capable of binding ["%C]benzylpenicillin (Figure 2A, lane
d). Purified PBP1* was thermolabile, similar to its M. leprae
PBP1* counterpart [19]. Incubation for 5 min at 37 °C led to a
loss of PB activity. The half-life of the purified protein was
15 min at 25 °C in buffer A containing 1% (w}v) Zwittergent
3–12.
Interaction of PBP1* with radioactive and non-radioactive b-
lactams
At 25 °C, the k
#
}K value of benzylpenicillin was 110000‡
11000 M−"[s−", in comparison with values of 5–10, " 50000, 800
and 150 M−"[s−" for M. leprae PBP1 and PBP1*, E. coli PBP1a and
1b respectively [19,20]. The k
$
value was ! 10−% s−". The k
#
}K
values for interaction of the membrane-bound PBP1* with
ampicillin, amoxycillin, cefoxitin, cefotaxime, ceftriaxone and
cefuroxime were 10000‡800, 20000‡2100, 3400‡200,
100000‡11000, 11000‡1000 and 76000‡8000 M−"[s−" re-
spectively. The effectiveness of ampicillin and amoxycillin in
acylating PBP1* is consistent with previous observations, dem-
onstrating the in itro activity of ampicillin [2] and amoxycillin
[1,3] against M. tuberculosis. Temocillin, piperacillin, methicillin
and moxalactam were ineffective in acylating PBP1* at concen-
trations up to 1 mM. The purified protein interacted with
["%C]benzylpenicillin and non-radioactive b-lactams with the
same affinity as the membrane-bound PBP.
Truncation of the N-terminal n-PB module of PBP1*
In the case of E. coli PBP1b, the prototype class A high-
molecular-mass PBP, the n-PB module has been shown to be
required both for the proper folding of the PBP as well as for the
transpeptidation function of the PB module [22]. Thus we
attempted to evaluate the role of the n-PB module in these
functions of M. tuberculosis PBP1*. In order to do so, successive
deletions of the conserved motifs of the n-PB module were carried
out by genetic manipulation. Deletion of the first conserved
motif of the N-terminal module was performed in the vector
pBAD-HisA at 37 °C, and the expression of the plasmid induced
at 30 °C using various arabinose concentrations [0.0002–0.2
(w}v)]. The lowest concentration of arabinose required for
expression was found to be 0.0002%. Even under these con-
ditions, (DV2-A64)PBP1* was present exclusively in the inclusion
bodies (results not shown). Consistent with this observations,
successive truncated versions of PBP1*, namely (DV2-
Q94)PBP1*, (DV2-S137)PBP1*, (DV2-L258)PBP1* and (DV2-
Q271)PBP1*, were localized to the inclusion bodies (results not
shown).
Purification of the PB module
Attempts to generate a functional PB module of PBP1b, the E.
coli class A high-molecular-mass PBP, have been unsuccessful
[22]. Thus we tested whether the PB module of PBP1* could be
obtained in a conformation competent to bind penicillin. The
smallest truncated derivative, (DV2-Q271)PBP1* (hereafter
designated PB-PBP1*), representing the PB module fused to the
N-terminal end of motif 6 of the n-PB module, localized to
inclusion bodies when expressed in E. coli. The expressed protein
was extracted from the inclusion bodies using 5 Mguanidine}HCl
in a solution containing 150 mM Tris}HCl (pH 8), 1 mM dithio-
threitol and 1 mM EDTA, and dialysed against different buffers
in order to obtain the ideal conditions for obtaining a refolded
protein, as judged by its stability and its ability to bind penicillin.
The protein was optimally refolded when dialysed against
400 mM Tris}HCl (pH 8) containing 20% (v}v) glycerol and
1 mM EDTA at 20 °C for 16 h. The yield of the solubilized
recombinant protein was 20% of that present in the inclusion
bodies. PB-PBP1* was purified by affinity chromatography on
Ni#+-NTA–agarose (Figure 2B), as described above, and judged
to be 90% pure by SDS}PAGE. PB-PBP1* was able to bind
penicillin with the same efficiency as the full-length PBP1*. The
k
#
}K for benzylpenicillin binding was determined to be
100000‡10000 M−"[s−".
Construction of s-PBP1*
The SecB protein binds to the first third of the precursor of the
maltose-binding protein, preventing its premature folding and
loss of competence for export [23]. To investigate the possibility
of a similar interaction with PBP1*, in-frame deletions of the N-
terminal module were generated. (DG95-Q143)PBP1* (hereafter
referred to as s-PBP1*) was obtained in the cell-free supernatant
of E. coli in a soluble, translocation-defective form (Figure 2C,
lane b). Chou–Fassman analysis suggested that the region
encompassed by residues Gly*&–Gln"%$ adopted a b-sheet struc-
ture. In order to localize s-PBP1*, periplasmic proteins obtained
after the conversion of cells expressing s-PBP1* into sphero-
plasts and the cytosolic extract obtained after lysis of spheroplasts
were separated by SDS}PAGE, electroblotted on to nitro-
cellulose and subjected to Western blotting using anti-His
antibodies. It was observed that 90‡5% of s-PBP1* was retained
in the cytosol. Under conditions in which 5% or more of the
# 2002 Biochemical Society
639Penicillin-binding protein 1* from Mycobacterium tuberculosis
expressed protein would be detectable if present in any fraction,
no s-PBP1* was detected in the periplasm by Western blotting
using anti-His antibodies (Figure 2C, lanes e–g). s-PBP1* was
purified by affinity chromatography on Ni#+-NTA–agarose and
judged to be 95% pure by SDS}PAGE (Figure 2C, lane c). The
protein was capable of binding penicillin with the same efficiency
(k
#
}Kfl 105000‡9000 M−"[s−") as the full-length protein (Fig-
ure 2C, lane d). Its thermostability was also comparable with
that of full-length PBP1*.
DISCUSSION
Analysis of the core-based clustering of the multimodular
PBPs by sequence alignments indicates that the class A PBPs of
M. tuberculosis and M. leprae form a distinct cluster [22]. M.
tuberculosis PBP1* described in the present study is most similar
in sequence to M. leprae PBP1* (Figure 1). The sequence
similarity and sensitivity of M. tuberculosis PBP1* to b-lactam
antibiotics suggest that it is the counterpart of M. leprae PBP1*
[19]. It also makes it an attractive target for antimycobacterial
chemotherapy. We demonstrate that the PB module retains its
ability to bind penicillin even in the absence of the majority of the
n-PB module. Deletion of the N-terminal 64 amino acid residues
gives rise to a protein that is exclusively localized in inclusion
bodies. The region encompassed by amino acid residues
Gly*&–Gln"%$ was found to be necessary for transport of PBP1*
to the membrane. s-PBP1* is a soluble derivative of the protein
probably representing a folded state, since it binds benzyl-
penicillin with the same catalytic efficiency as the full-length
protein. This is the first report of the in io overexpression of a
soluble derivative of a class A high-molecular-mass PBP capable
of binding penicillin. It promises to be an important step towards
the elucidation of the structure of the protein.
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